Selling And Administration Expenses Lave om Dato
AbbVie USD 3.61B 273M 2023-12
Alnylam Pharmaceuticals USD 198.12M 1.05M 2023-12
Amarin USD 45.46M 5.5M 2023-09
AstraZeneca USD 3.91B 194M 2023-09
BioCryst Pharmaceuticals USD 50.65M 349K 2023-09
Esperion Therapeutics USD 33.24M 719K 2023-09
GlaxoSmithKline GBP 2.18B 6M 2023-09
Halozyme Therapeutics USD 37.61M 2.34M 2023-12
Heron Therapeutics USD 24.6M 11.84M 2023-09
Ionis Pharmaceuticals USD 71.01M 1.06M 2023-12
Nektar Therapeutics USD 21.15M 3.28M 2023-09
Neurocrine Biosciences USD 204.2M 17.6M 2023-09



Amarin Salgsomkostninger Og Administration - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Mar 2024.